Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)

STO:IBT.B Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	144.01	223.39	329.06	335.84	386.75
Cash & Short-Term Investments	144.01	223.39	329.06	335.84	386.75
Cash Growth	-35.53%	-32.11%	-2.02%	-13.16%	-8.66%
Other Receivables	2.79	4.77	6.74	1.78	1.2
Receivables	2.79	4.77	6.74	1.78	1.2
Prepaid Expenses	6.81	2.46	5.76	1.41	9.14
Other Current Assets	-0	0	-	0	-
Total Current Assets	153.61	230.61	341.56	339.03	397.09
Long-Term Investments	0.07	0.07	0.07	0.07	0.05
Long-Term Deferred Charges	8.07	8.89	9.7	10.52	11.33
Other Long-Term Assets	-	-	-0	-	-
Total Assets	161.75	239.57	351.33	349.62	408.48
Accounts Payable	43.86	46.99	30.07	8.75	4.8
Accrued Expenses	12.17	21.89	15.33	8.67	7.65
Other Current Liabilities	0.39	0.42	0.78	0.5	0.78
Total Current Liabilities	56.42	69.3	46.18	17.91	13.22
Other Long-Term Liabilities	-	-	-	0	-
Total Liabilities	56.42	69.3	46.18	17.91	13.22
Common Stock	3.67	3.67	3.67	3.06	3.06
Additional Paid-In Capital	768.84	768.84	766.83	670.93	669.02
Retained Earnings	-667.18	-602.25	-465.35	-342.28	-276.83
Comprehensive Income & Other	-0	-	0	-0	-
Shareholders' Equity	105.33	170.26	305.15	331.71	395.25
Total Liabilities & Equity	161.75	239.57	351.33	349.62	408.48
Net Cash (Debt)	144.01	223.39	329.06	335.84	386.75
Net Cash Growth	-35.53%	-32.11%	-2.02%	-13.16%	-8.66%
Net Cash Per Share	10.69	16.58	26.61	29.92	34.45
Filing Date Shares Outstanding	13.47	13.47	13.47	11.23	11.23
Total Common Shares Outstanding	13.47	13.47	13.47	11.23	11.23
Working Capital	97.19	161.31	295.38	321.12	383.87
Book Value Per Share	7.82	12.64	22.65	29.55	35.21
Tangible Book Value	105.33	170.26	305.15	331.71	395.25
Tangible Book Value Per Share	7.82	12.64	22.65	29.55	35.21

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.